Acorah Software Products - Accounts Production16.1.300falsetruefalsetrueNo description of principal activity1 September 202331 August 202431 August 202415083170M Khaniso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure150831702023-08-31150831702024-08-31150831702023-09-012024-08-3115083170frs-core:CurrentFinancialInstruments2024-08-3115083170frs-bus:PrivateLimitedCompanyLtd2023-09-012024-08-3115083170frs-bus:FilletedAccounts2023-09-012024-08-3115083170frs-bus:Micro-entities2023-09-012024-08-3115083170frs-bus:AuditExempt-NoAccountantsReport2023-09-012024-08-3115083170frs-bus:Director12023-09-012024-08-31
Registered number: 15083170
MAK Pharma Ltd
Unaudited Financial Statements
For The Year Ended 31 August 2024
M.R Accountants Ltd
MAK Pharma Ltd
Balance Sheet
As At 31 August 2024
Balance Sheet
Registered number: 15083170
2024
£
Current assets
11,756
Creditors: Amounts Falling Due Within One Year
(3,981)
NET CURRENT ASSETS
7,775
TOTAL ASSETS LESS CURRENT LIABILITIES
7,775
NET ASSETS
7,775
CAPITAL AND RESERVES
7,775
Notes
1.General Information
MAK Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15083170. The registered office is 30 Curzon Crescent, Barking, IG11 0JY.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 1
1
For the year ending 31 August 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.